Advanta India Limited is expected to expand its revenue at a CAGR of 24.1% from 2012-2017. The company has entered into a GM corn agreement with Monsanto for Brazil and Philippines. This agreement is expected to give its results in 2015. EDITDA of the company is expected to be a little under pressure as the company is focusing on research and development expenditures. The company is planning to introduce 15 new products which will generate positive cash flow for the company and will increase its revenues. Also increase in research and development expenditure will improve the quality of current products of the company. This will lead to production of more cost efficient products in future and will increase the operating margin of the company.
The report focuses on providing analysis’s on the company’s valuation in the industry and also provides for a detailed analysis of the company’s enterprise value and it’s positioning against its competitors. The company has showcased a revenue multiple of 2.2x as on 31st December 2012. The report inculcates a comprehensive analysis of the company’s balance sheet, cash flow statement and income statement. The future projections of the same have been included in the report complemented with the future forecast of company’s ration analysis.
For more information on the Equity Research Report please refer to the below mentioned link:
http://www.kenresearch.com/detail-company-report/12/advanta-india.html